Science Explorer Back to mapMap
Discussion
Nonprofit · Camperdown · Australia

GI Cancer Institute

gicancer.org.auROR OpenAlex
Research works
1
fractional, all time
Citations
1
0.7 per fractional work
Top-10% rate
2.3%
all institutions 10.0%
Open access
13%
world 40%
International
16%
world 18%
GI Cancer Institute

Not ranked overall: GI Cancer Institute is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does GI Cancer Institute work in?

In all years, 87% of research at GI Cancer Institute is in Health Sciences, 7% in Life Sciences. Its largest fields are Medicine (87%), Biochemistry, Genetics and Molecular Biology (7%), Psychology (7%). It does 1.3× the world's share of Health Sciences.

Health Sciences: 1 fractional works · 86.7% of its workMedicine: 1 fractional works · 86.7% of its workLife Sciences: 0 fractional works · 6.7% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 6.7% of its workSocial Sciences: 0 fractional works · 6.7% of its workPsychology: 0 fractional works · 6.7% of its workALL ITS WORKGI CancerInstitute2fractional works, all years
Life Sciences7%Health Sciences87%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 3 fields, with their numbers
    1. Medicine186.7%
    1. Biochemistry, Genetics and Molecular Biology06.7%
    1. Psychology06.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from GI Cancer Institute?

The most cited paper from GI Cancer Institute is "Electromyography in the prognostication of recovery in patients with acute peripheral facial nerve palsy: A systematic review" (George A. Petrides, Raymond R. Hayler, Jennifer W. Lee et al., 2023), with 8 citations. Next come "260MO AGITG ASCEND study: Randomised, double-blind phase II study of certepetide (CERT) or placebo (PLA) added to gemcitabine plus nab-paclitaxel in patients with untreated metastatic pancreatic ductal adenocarcinoma (mPDAC): Cohort B progression-free survival (PFS) results" (1) and "2219P AGITG ASCEND: Randomised, double-blind phase II trial of certepetide (CERT) or placebo (PLA) with gemcitabine (Gem) + nab-paclitaxel (Nab) in patients with untreated metastatic pancreatic ductal adenocarcinoma (mPDAC): Updated results including planned pooled placebo analysis" (0).

Most cited papers
#PaperReleasedCitations
1 Electromyography in the prognostication of recovery in patients with acute peripheral facial nerve palsy: A systematic review George A. Petrides, Raymond R. Hayler, Jennifer W. Lee et al. · Clinical Otolaryngology Review 28 Apr 2023 8
2 260MO AGITG ASCEND study: Randomised, double-blind phase II study of certepetide (CERT) or placebo (PLA) added to gemcitabine plus nab-paclitaxel in patients with untreated metastatic pancreatic ductal adenocarcinoma (mPDAC): Cohort B progression-free survival (PFS) results A. Dean, M. Harris, K. Sjoquist et al. · Annals of Oncology Open access Jul 2025 1
3 2219P AGITG ASCEND: Randomised, double-blind phase II trial of certepetide (CERT) or placebo (PLA) with gemcitabine (Gem) + nab-paclitaxel (Nab) in patients with untreated metastatic pancreatic ductal adenocarcinoma (mPDAC): Updated results including planned pooled placebo analysis A. Dean, Marion Harris, K. Sjoquist et al. · Annals of Oncology Open access Sep 2025 0
All 3 most cited papers, with filters and sorting

Which research topics does GI Cancer Institute publish most on?

By volume in 2022-now: Trigeminal Neuralgia and Treatments, Facial Nerve Paralysis Treatment and Research, Body Image and Dysmorphia Studies and Cancer Immunotherapy and Biomarkers.

Trigeminal Neuralgia and…0Trigeminal Neuralgia and Treatments: 0 fractional worksFacial Nerve Paralysis T…0Facial Nerve Paralysis Treatment and Research: 0 fractional worksBody Image and Dysmorphi…0Body Image and Dysmorphia Studies: 0 fractional works
Pathology and Forensic MedicineNeurologyClinical Psychology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Trigeminal Neuralgia and Treatments Pathology and Forensic Medicine 0 works
  2. 2 Facial Nerve Paralysis Treatment and Research Neurology 0 works
  3. 3 Body Image and Dysmorphia Studies Clinical Psychology 0 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 0 works
  5. 5 Pancreatic and Hepatic Oncology Research Oncology 0 works
  6. 6 Cutaneous Melanoma Detection and Management Oncology 0 works
  7. 7 Melanoma and MAPK Pathways Molecular Biology 0 works
  8. 8 Cancer Genomics and Diagnostics Cancer Research 0 works
  9. 9 Lung Cancer Research Studies Oncology 0 works
  10. 10 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available12.6%not open87.4%

World: 40% of research is openly available.

with international co-authors16.1%domestic only83.9%

World: 18% is written across borders.

How has GI Cancer Institute's research output changed?

still counting201520202025

Other research institutions in Camperdown

All research institutions in Camperdown

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about GI Cancer Institute. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.